Sarah E. Diver

Groby Road
Leicester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies.

Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies.

Journal: The Lancet. Respiratory medicine

Published: March 02, 2026

Global asthma and pest control: bugs and WASPs.

Global asthma and pest control: bugs and WASPs.

Journal: Thorax

Published: February 09, 2026

Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers.

Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers.

Journal: Chest

Published: September 22, 2025

Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.

Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.

Journal: The Journal of allergy and clinical immunology

Published: December 16, 2024

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials.

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials.

Journal: The Lancet. Respiratory medicine

Published: December 09, 2024

Under the weather: an epidemic thunderstorm asthma event in Leicester, June 2023.

Under the weather: an epidemic thunderstorm asthma event in Leicester, June 2023.

Journal: BMJ open respiratory research

Published: May 21, 2024

Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.

Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.

Journal: The Journal of allergy and clinical immunology

Published: April 16, 2024

Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.

Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma.

Journal: NEJM evidence

Published: February 06, 2024

Improving Outcomes in Difficult Asthma: Watch and Weight.

Improving Outcomes in Difficult Asthma: Watch and Weight.

Journal: Chest

Published: March 03, 2023

Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Novel Therapeutic Strategies in Asthma-Chronic Obstructive Pulmonary Disease Overlap.

Journal: Immunology and allergy clinics of North America

Published: August 14, 2022

Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.

Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.

Journal: American journal of respiratory and critical care medicine

Published: May 13, 2022

Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE).

Corticosteroid Responsiveness Following Mepolizumab in Severe Eosinophilic Asthma-A Randomized, Placebo-Controlled Crossover Trial (MAPLE).

Journal: The journal of allergy and clinical immunology. In practice

Published: January 19, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026